Endothelium-dependent and -independent vascular dysfunction in type 1 diabetes: Role of conventional risk factors, sex, and glycemic control

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 6, 2003, Pages 1048-1054

  Chan, Norman Nor ^a,b   Vallance, Patrick ^a   Colhoun, Helen Martina ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Diabetes mellitus; Endothelial dysfunction; Nitric oxide; Plethysmography

Indexed keywords

ACETYLCHOLINE; BRADYKININ; GLYCERYL TRINITRATE; NITROGEN OXIDE;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOREARM BLOOD FLOW; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ADULT; BLOOD GLUCOSE; BRADYKININ; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROGLYCERIN; OMEGA-N-METHYLARGININE; PLETHYSMOGRAPHY; REGIONAL BLOOD FLOW; RISK FACTORS; SEX FACTORS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0038797794     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000072968.00157.6B     Document Type: Article

References (24)

1. Swerdlow AJ, Jones ME. Mortality during 25 years of follow-up of a cohort with diabetes. Int J Epidemiol. 1996;25:1250-1261.
2. Morrish NJ, Stevens LK, Fuller JH, Jarrett RJ, Keen H. Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO multinational study of vascular disease in diabetics. Diabetologia. 1991;34:590-594.
3. Radomski MW, Salas E. Nitric oxide: biological mediator, modulator and factor of injury. Its role in the pathogenesis of atherosclerosis. Atherosclerosis. 1995;118(suppl):S69-S80.
4. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14:753-759.
5. De Vriese AS, Verbeuren TJ, Van D, V, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130:963-974.
6. Chan NN, Vallance P, Colhoun HM. Nitric oxide and vascular responses in type I diabetes. Diabetologia. 2000;43:137-147.
7. Vervoort G, Wetzels JF, Lutterman JA, van Doorn LG, Berden JH, Smits P. Elevated skeletal muscle blood flow in noncomplicated type 1 diabetes mellitus: role of nitric oxide and sympathetic tone. Hypertension. 1999;34:1080-1085.
8. Colhoun HM, Rubens MB, Underwood SR, Fuller JH. The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. J Am Coll Cordiol. 2000;36:2160-2167.
9. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulindependent diabetes. J Clin Invest. 1992;90:2548-2554.
10. Palmer SM, Kaufman RA, Salamone SJ, Blake-Courtney J, Bette W, Wahl HP, Furrer F. Cobas Integra: clinical laboratory instrument with continuous and random-access capabilities. Clin Chem. 1995;41:1751-1760.
11. Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med. 1992;11:1685-1704.
12. Omar RZ, Wright EM, Turner RM, Thompson SG. Analysing repeated measurements data: a practical comparison of methods. Stat Med. 1999;18:1587-1603.
13. Benjamin N, Cockcroft JR, Collier JG, Dollery CT, Ritter JM, Webb DJ. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol. 1989;412:543-555.
14. Chan NN, Vallance PJ. Macallister RJ. Hingorani AD. Colhoun HM. Impaired nitric oxide response in resistance vessels in human type I diabetes in vivo. Circulation. 2000;102:326. Abstract.
15. Smits P, Kapma JA, Jacobs MC, Lutterman J, Thien T. Endotheliumdependent vascular relaxation in patients with type 1 diabetes. Diabetes. 1993;42:148-153.
16. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulindependent diabetes mellitus. Circulation. 1993;88:2510-2516.
17. Clarkson P, Celermajer DS, Donald AE, Sampson M, Sorensen KE, Adams M, Yue DK, Betteridge DJ, Deanfield JE. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol. 1996;28:573-579.
18. O'Byrne S, Forte P, Roberts LJII, Morrow JD, Johnston A, Anggåd E, Leslie RDG. Benjamin N. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes. 2000;49:857-862.
19. Lloyd CE, Kuller LH, Ellis D, Becker DJ, Wing RR, Orchard TJ. Coronary artery disease in IDDM: gender differences in risk factors but not risk Arterioscler Thromb Vasc Biol. 1996;16:720-726.
20. Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, Idzior-Walus B. The EURODIAB IDDM complications study group: cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care. 1996;19:689-697.
21. Mortensen HB, Hougaard P, for the Hvidore Study Group on Childhood Diabetes. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. Diabetes Care. 1997;20:714-720.
22. Rothman KJ, Greenland S. Matching. In: Rothman KJ, Greenland S, eds. Modern Epidemiology. Philadelphia: Lippincott-Raven: 1998:147-162.
23. Wilsgaard T, Jacobsen BK, Schirmer H, Thune I, Lochen ML, Njolstad I, Amesen E. Tracking of cardiovascular risk factors: the Tromso study, 1979-1995. Am J Epidemiol. 2001;154:418-426.
24. Vallance P. Nitric oxide.Biologist (London). 2001;48:153-158.